BioPharm International Supplements, October 2010 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International Supplements, October 2010
Peer-Reviewed Research
Characterization of Aluminum Hydroxide Gel and Oil-in-Water Emulsion Formulations Containing CpG ODNs
By Christopher B. Fox , Timothy S. Dutill , James Chesko , Ryan C. Anderson , Steven G. Reed , Thomas S. Vedvick
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Release and Stability Testing Programs for a Novel Virus-Like Particle Vaccine
By Steven Pincus , Sarathi Boddapati , Jingning Li , Travis Sadowski
Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
Sterilizing Filtration of Adjuvanted Vaccines: Ensuring Successful Filter Qualification
By Annelies Onraedt, PhD , Martha Folmsbee, PhD , Anil Kumar , Jerold Martin
Filterability and bacterial retention must be verified very early in process development to ensure successful sterilizing filtration validation.
An Alternative Platform for Rapid Production of Effective Subunit Vaccines
By Jyothi Jayaram , Ashot Papoyan , Yelena Bisharyan , Donna Cassidy-Hanley , Xujie Zhang , Paul Colussi , Judith A. Appleton , Lucille Gagliardo , Theodore G. Clark
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).

ADVERTISEMENT

ADVERTISEMENT

Click here